D-1167-2017 Class II Terminated
FDA drug recall D-1167-2017 was initiated by Pfizer Inc. on Aug 22, 2017 and is designated Class II. Reason for recall: Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. The recall status is terminated (terminated Feb 19, 2023). Affected quantity: 115,370 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 27, 2017
- Initiation Date
- Aug 22, 2017
- Termination Date
- Feb 19, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 115,370 vials
Product description
HYDROmorphone HCl Injection, USP, 2 mg/mL, 1mL Single-use vial, packaged in cartons of 25 vials, Rx only, Hospira, Inc., Lake Forest, IL 60045 USA, NDC 0409-3365-11 (carton) and 0409-3365-01(vial)
Reason for recall
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process.
Distribution pattern
United States Nationwide (including Puerto Rico) and Singapore
Code information
Lot: 760853A
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1167-2017
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Pfizer Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.